William Aird: Anemia of Inflammation Not Just a Trade-Off but a Possible Compensation
William Aird, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:
”Anemia of inflammation: trade – off or adaptation?
We usually think of anemia of inflammation as a cost.
Iron is sequestered to limit microbial growth, and red cell production falls as a consequence.
But there may be another way to look at it.
The acute phase response increases plasma viscosity, driven in part by fibrinogen.
At the same time, hematocrit falls.
Since hematocrit is a major determinant of whole-blood viscosity, even a modest reduction may offset the rheologic effects of inflammation.
In other words:
- Inflammation thickens the plasma.
- Anemia thins the suspension.
Two observations are at least consistent with this idea:
- In critical care, restrictive transfusion strategies (hemoglobin ~7 g/dL) perform as well as, or better than, more liberal approaches.
- And in anemia of inflammation, hemoglobin levels tend to plateau rather than fall indefinitely, often remaining in the 7–10 g/dL range unless another process is present.
There appears to be a floor.
Not necessarily just a trade-off.
Possibly a compensation.”
Other posts featuring William Aird on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients